0000914475-13-000013.txt : 20130128
0000914475-13-000013.hdr.sgml : 20130128
20130128174713
ACCESSION NUMBER: 0000914475-13-000013
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20130116
FILED AS OF DATE: 20130128
DATE AS OF CHANGE: 20130128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gano Kyle
CENTRAL INDEX KEY: 0001567160
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 13552921
MAIL ADDRESS:
STREET 1: NEUROCRINE BIOSCIENCES, INC.
STREET 2: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2013-01-16
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001567160
Gano Kyle
NEUROCRINE BIOSCIENCES, INC.
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Business Dev Officer
Common Stock
22488
D
Employee Stock Option (right to buy)
10.90
2013-09-26
Common Stock
2400
D
Employee Stock Option (right to buy)
5.00
2015-03-12
Common Stock
9000
D
Employee Stock Option (right to buy)
2.59
2017-05-11
Common stock
40000
D
Employee Stock Option (right to buy)
5.76
2021-08-25
Common Stock
75000
D
Employee Stock Option (right to buy)
8.66
2022-01-12
Common Stock
70000
D
Employee Stock Option (right to buy)
8.65
2023-01-10
Common Stock
60000
D
Restricted Stock Unit
0
Common Stock
10000
D
The option vested in annual installments over three years. The first installment became exercisable on September 26, 2007.
The option vested in annual installments over three years. The first installment became exercisable on March 12, 2009.
The option vests in monthly installments over three years. The first installment became exercisable on June 11, 2010.
The option vests in monthly installments over three years. The first installment became exercisable on September 25, 2011.
The option vests in monthly installments over four years. The first installment became exercisable on February 12, 2012.
The option vests in monthly installments over four years. The first installment becomes exercisable on February 10, 2013.
The restricted stock units will vest annually at 1/4 of the units vesting on January 10, 2014, January 10, 2015, January 10, 2016 and January 10, 2017, respectively.
Each restricted stock unit represents a contingent right to receive one share of Neurocrine Biosciences, Inc. Common Stock.
Margaret E. Valeur- Jensen, By Power of Attorney
2013-01-28
EX-24
2
ganolpoa.htm
POWER OF ATTORNEY